Sagimet Biosciences Inc.SGMTNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
34.24%
↑ 336% above average
Average (14q)
7.85%
Historical baseline
Range
High:100.43%
Low:-52.76%
Volatility
1951.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 34.24% |
| Q2 2025 | -52.76% |
| Q1 2025 | 7.92% |
| Q4 2024 | 12.35% |
| Q3 2024 | 100.43% |
| Q2 2024 | 19.97% |
| Q1 2024 | -6.97% |
| Q4 2023 | 14.08% |
| Q3 2023 | 6.03% |
| Q2 2023 | 4.21% |
| Q1 2023 | -23.26% |
| Q4 2022 | -14.49% |
| Q3 2022 | 7.33% |
| Q2 2022 | 8.66% |
| Q1 2022 | 0.00% |